Disclosure Panels Details Page

Central Nervous System Cancers Panel - Disclosures as of 10/17/2012

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Mario Ammirati MD, MBA None None None None None
Philip Bierman MD None None None None NA -
Henry Brem MD Arbor Pharmaceuticals
Bristol-Myers Squibb Company
Accelerating Combination Therapies
Asclepix Therapeutics
B*Cured: Flighting Brain Cancer
Camden Partners
Galen Robotics
InSightec
LikeMinds, Inc.
Nurami Medical
Perosphere Inc.
StemGen
None None NA
Nicholas Butowski MD AbbVie, Inc.
Amgen Inc.
Bayer HealthCare
Ipsen
Jazz Pharmaceuticals Inc.
Karyopharm Therapeutics
Medicenna
Novartis Pharmaceuticals Corporation
AbbVie, Inc.
Amgen Inc.
Cordance
None None NA
Marc Chamberlain MD NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas Novartis Advisory Board Nativis
Neonc Inc
None None -
Lisa DeAngelis MD None None None None NA
Robert Fenstermaker MD Celgene Corporation
MimiVax
None prIME Oncology MimiVax None
Allan Friedman MD None None None None NA -
Lauren Gallagher None None None None None -
Mark Gilbert MD RTOG Trial Abbott Laboratories
EMD Serono
Genentech, Inc.
Merck & Co., Inc.
None None NA
Kristina Gregory MSN, RN, OCN None None None None NA -
Deneen Hesser None None National Cancer Institute None NA
Maria Ho None None None None NA -
Matthias Holdhoff MD, PhD None None None None NA
Larry Junck MD None Orbus Pharmaceutical None None NA
Ronald Lawson MD, FACP None None None None NA
Jay Loeffler MD Advanced Oncotherapy
Mevion Corporation
None None None NA
Moshe Maor MD None None None None NA
Joan McClure MS None None None None NA -
Nicole McMillian MS None None None None NA -
Paul Moots MD None None None None NA
Tara Morrison MD, FRCPC None Merck & Co., Inc. None None NA
Maciej Mrugala MD, PhD, MPH Bristol-Myers Squibb Company
Celldex Therapeutics
ImmunoCellular Therapeutics
Novocure
Novocure
Xcenda
None None None
Louis Nabors MD University of Pennsylvania None None None NA
Herbert Newton MD None Genentech, Inc.
Novocure
Genentech, Inc.
Novocure
Sigma-Tau Pharmaceuticals, Inc.
None NA -
Jana Portnow MD None None None None NA
Jeffrey Raizer MD AbbVie, Inc.
CellDex
Genentech, Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Plexxikon
ZioPharm
AbbVie, Inc.
Agenus
Aurasense
Bristol-Myers Squibb Company
CytRx
Genentech, Inc.
Novocure
Proximagen
Threshold
Genentech, Inc.
Novocure
Prime Oncology
None None
Lawrence Recht MD Nektar Therapeutics
sanofi-aventis U.S.
None None None None
Dennis Shrieve MD, PhD None None None None NA
Allen Sills MD None None None None NA
David Tran MD, PhD Celldex
Merck & Co., Inc.
Northwest Biotherapeutics, Inc.
Novocure
Novocure Novocure None NA
Nam Tran MD, PhD None None None None None
Frank Vrionis MD, PhD, MPH Globus
Republic Spine
Florida Board of Medicine
Southeastern Brain Tumor Association
None None None
Patrick Wen MD None Agios, Inc.
Bayer HealthCare
Boston Pharma
Imvax
Integral Health
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Novocure
Nuvation Bio
None None NA